Filing Details
- Accession Number:
- 0001209191-19-011184
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-19 17:07:24
- Reporting Period:
- 2019-02-15
- Accepted Time:
- 2019-02-19 17:07:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820081 | Cambrex Corp | CBM | Pharmaceutical Preparations (2834) | 222476135 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227835 | Gregory Sargen | One Meadowlands Plaza East Rutherford NJ 07073 | Cfo & Evp, Corp. Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-15 | 12,000 | $0.00 | 38,227 | No | 4 | A | Direct | |
Common Stock | Disposition | 2019-02-15 | 5,802 | $37.45 | 32,425 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Pursuant to settlement of a performance share award.
- Broker-assisted sale of 5,802 shares to cover the payment of withholding tax liability from the settlement of a performance share award.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.32 to $37.57 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.